Kura Oncology Inc (KURA) returns
Kura Oncology returns over 10 years
$1,000 invested in Kura Oncology ten years ago was worth $2,359 at the close on October 30, 2026, with dividends reinvested: an average return of 9.0% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -4.2% | — | $957.98 | -0.9% |
| 3 months | +10.2% | — | $1,102 | +2.1% |
| Year to date | -1.3% | — | $987.49 | +11.7% |
| 1 year | -1.7% | — | $982.76 | +12.4% |
| 3 years | +25.9% | +8.0% | $1,259 | +88.5% |
| 5 years | -37.5% | -9.0% | $624.85 | +76.0% |
| 10 years | +135.9% | +9.0% | $2,359 | +316.6% |
Kura Oncology return by calendar year
| Year | KURA | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -1.3% | +11.7% | -12.9% |
| 2025 | +19.3% | +17.7% | +1.6% |
| 2024 | -39.4% | +24.9% | -64.3% |
| 2023 | +15.9% | +26.2% | -10.3% |
| 2022 | -11.4% | -18.2% | +6.8% |
| 2021 | -57.1% | +28.7% | -85.9% |
| 2020 | +137.5% | +18.4% | +119.2% |
| 2019 | -2.1% | +31.2% | -33.3% |
| 2018 | -8.2% | -4.6% | -3.7% |
| 2017 | +159.3% | +21.7% | +137.6% |
| 2016 | -29.8% | +12.0% | -41.8% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Kura Oncology Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.